Inogen | INGN - Current Liabilities


Inogen reported $64.94M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Accuray USD 194.61M 2.03M Sep/2025
AngioDynamics USD 77.97M 10.62M Feb/2025
Artivion USD 85.84M 19.17M Sep/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 5.44B 111M Dec/2025
Chart Industries USD 2.13B 90.4M Dec/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dexcom USD 2.14B 1.19B Dec/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.94B 1.6B Sep/2025
Orthofix International USD 159.85M 11.47M Sep/2025
Philips EUR 7.51B 479M Dec/2025
ResMed USD 1.25B 7.39M Dec/2025
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
X T L Biopharmaceuticals USD 761K 1.45M Jun/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025